Refer to the Community Needs Assessment Guidance and associated webinars for additional specifics (link below)
Notably, beyond its glycemic control benefits, researchers and clinicians observed that patients using Wegovy (semaglutide) dosage for weight loss often experienced significant results
Considering the promising performance of C-KIT inhibitors in MM, now more efforts have been focused on the understanding of the acquired resistance mechanism and the development of new blocking agents to overcome resistance, offering hope for patients with advanced MM and limited treatment options
Under the new plan, Medicare beneficiaries would gain access to these medications at a significantly reduced price, potentially helping users who have struggled with affordability
plus secondary sources on GLP-1 adverse effect profiles, contraindication guidance (FDA prescribing information for Ozempic, Wegovy, Mounjaro), and post-discontinuation weight regain data